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INTRODUCTION
Gadoxetic acid (Primovist®, Bayer Schering Pharma AG, Ber-
lin, Germany) is a magnetic resonance imaging (MRI) contrast 
agent specialized for liver imaging. Gadoxetic acid acts as both 
an extracellular contrast and hepatocyte selective contrast 
agent, and approximately half of the injected dose is internal-
ized by hepatocytes and is subsequently excreted into the bile.1,2 
This unique property is attributed to the fact that gadoxetic 
acid is transported from the circulation into hepatocytes by or-
ganic anion transporting polypeptide (OATP) 1B1 and 1B3, 
which are carrier proteins exclusively expressed in function-
al hepatocytes.3 Consequently, the normal liver parenchyma 
shows selective enhancement at the hepatobiliary phase, which 
improves the detection of focal liver lesions lacking functional 
hepatocytes.4 
Multistep hepatocarcinogenesis involves the accumulation 
Expression of Organic Anion Transporting Polypeptides 
in an H-Ras 12V Transgenic Mouse Model 
of Spontaneous Hepatocellular Carcinoma 
Honsoul Kim1,2*, Junjeong Choi3*, Dae-Yeul Yu4, and Hye Jin Choi5
1Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 
2Department of Health Science and Technology, SAIHST, Sungkyunkwan University, Seoul;
3Department of Pharmacy, College of Pharmacy, Yonsei Institute of Pharmaceutical Science, Yonsei University, Incheon; 
4Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon; 
5Division of Oncology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
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Materials and Methods: Tumor nodules were harvested from transgenic H-Ras 12V mice. Hematoxylin and eosin-stained slides 
were examined for tumor differentiation and high-grade pathological components (tumor necrosis, thickened trabeculae, or vas-
cular invasion). Immunohistochemistry of OATP 1B1/1B3 was performed, and OATP expression was assessed. 
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ent (n=10). Among the well-differentiated HCCs without high-grade pathological components (n=49), OATP expression was nega-
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grade pathological components (n=10), OATP expression was negative, weak positive, and moderate positive in one, two, and 
seven cases, respectively. The ratio of positive OATP 1B1/1B3 expressing tumors was higher in HCCs with high-grade pathological 
components than in those without high-grade pathological components (p=0.004).
Conclusion: Our findings support those of previous clinical studies that have reported the frequent appearance of gadoxetic acid-
enhanced MRI in moderately differentiated HCC. 
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of epigenetic and genetic alterations and the occurrence of suc-
cessive selection and expansion of less differentiated parent 
nodules.5 The role of OATP1B1 and OATP1B3 signaling path-
ways in multistep hepatocarcinogenesis remains poorly un-
derstood, but their expression has been reported to decrease 
during the development of hepatocellular carcinoma (HCC).6 
The expression of these molecules is maintained in regenerat-
ing nodules and low-grade dysplastic nodules, but is low or ab-
sent in high-grade dysplastic nodules, early, and progressed 
HCCs.7-9 The decrease in OATP expression can proceed portal 
venous flow reduction10 and/or increase in arterial flow,8 sug-
gesting that the hepatobiliary phase enhancement may facili-
tate imaging-based diagnosis of HCC at earlier stages.5
However, multiple studies have reported the presence of an 
HCC subgroup in approximately 5–12% of the cases, which 
demonstrates paradoxical hyperintensity of gadoxetic acid in 
the hepatobiliary phase MRI images.7,11-13 This subgroup has 
distinct features such as being biologically indolent, lower tu-
mor grade, less frequent vascular invasion, and longer recur-
rence-free survival after resection.12,14-16 However, whether para-
doxical enhancement mainly occurs in well-differentiated HCC 
or moderately differentiated HCC remains unclear.8,17-20 We 
speculate that the discrepancies among different studies may 
be the result of substantial inter-individual variation in the 
study populations, underlying liver diseases, predisposing fac-
tors, genetic background, and lifestyle that lead to heteroge-
neous HCC presentation.
In the current study, we used a genetically modified H-ras 12V 
mouse model of spontaneous HCC21,22 to examine the expres-
sion profile of OATPs during tumor differentiation. Similar to 
HCC patients, these mice showed multistep hepatocarcino-
genesis but with minimal inter-individual variation. A uniform 
oncogenic stimulus drives hepatocarcinogenesis in these mice, 
and the differences in genetic background and environment 
are negligible. 
MATERIALS AND METHODS
This study was approved by the Institutional Animal Care and 
Use Committee of Yonsei University Severance Hospital (2017-
0330), and the animal experiments were conducted in accor-
dance with the National Institute of Health Guide for the Care 
and Use of Laboratory Animals.
Transgenic mice and treatment
H-Ras 12V transgenic mice were kindly provided by Professor 
Dae-Yeul Yu of Korea Research Institute of Bioscience and 
Biotechnology. Transgenic lines were established by mating 
these mice with C57BL/6 mice. Genotyping was performed us-
ing polymerase chain reaction (PCR) with forward primer 5'- 
CTAGGGCTGCAGGAATTC-3' and reverse primer 5'-GTAGTT-
TAACACATTATACACT-3'. PCR in transgenic mice yielded a 
711 bp product.23 All mice were fed a standard normal diet ad 
libitum with free access to water. Only male mice were used for 
experiments, and the mice were housed in a specific pathogen-
free facility for up to 13 months to allow sufficient incubation 
time required for spontaneous hepatocarcinogenesis (Fig. 1).
MRI acquisition
Initially, nine mice were subjected to gadoxetic acid-enhanced 
MRI. The mice were scanned with a horizontal-bore 9.4T mi-
cro-MRI scanner (Biospec 94/20 USR, Bruker Biospin Inc., Bil-
lerica, MA, USA) while under general anesthesia. The mice were 
placed in an induction chamber, and anesthesia was induced 
with a mixture of 3% isoflurane and 97% oxygen. Then, anes-
thesia was maintained during imaging by supplying a mixture 
of 2% isoflurane and 99.2–98% oxygen at a flow rate of 1.5/min 
administered with an animal nose/mouth mask. All animals 
were positioned prone in a dedicated animal cradle heated via 
a thermostat-driven water bath. A pressure transducer consist-
ing of a small air cushion was attached to the abdominal wall 
to monitor the respiratory rate during the MR procedures. For 
the contrast-enhanced study, 1.2 μL/g (body weight) gadoxetic 
acid (Primovist®) was injected through the tail vein. The dos-
age of gadoxetic acid was determined by multiplying the trans-
lation factor by the body surface area to the recommended hu-
man dosage.24 Hepatobiliary phase images were obtained 15 
min after contrast agent injection. To perform radiological-path-
ological correlation, the tumor samples were sampled and cor-
related with the corresponding nodules from the MRI images. 
However, upon dissection, many small tumors were crowded 
within the mouse liver tumors. Unlike the human liver, in which 
each lobe is fixed, the lobes of the mouse liver were separated 
while being connected only at the hilum (Fig. 1A). Consequent-
ly, the position of each lobe was different between the MR im-
ages and the dissected liver. This complicated the histological 
imaging correlation, especially if the nodules were small or 
crowded.  
Histological examination and immunohistochemistry
Male mice (8–13 months old) were sacrificed under anesthe-
sia to obtain tumor samples. For immunofluorescence, tumor 
samples were initially fixed in 4% paraformaldehyde overnight, 
incubated in 20% sucrose solution at 4°C overnight 10 μm thick-
ness were cut, and anti-CD31 antibody (MAB1398Z, Millipore, 
Billerica, MA, USA) and Cy3-conjugated anti-smooth muscle 
actin (Sigma-Aldrich, St. Louis, MO, USA) were used for immu-
nofluorescence. An LSM 510 confocal microscope equipped with 
argon and helium-neon lasers (Carl Zeiss, Oberkochen, Germa-
ny) was used to obtain images.
Tumor nodules in the liver were dissected and fixed in 10% 
buffered formalin overnight. Samples were then embedded in 
paraffin and sectioned at 5-mm intervals. The tumor nodule 
was matched during sampling with gadoxetic acid-enhanced 
MRI for the radiological-pathological correlation. Tumor nod-
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ules that were difficult to correlate with the MRI images were 
marked. 
Hematoxylin and eosin (H&E) staining and immunohisto-
chemistry were performed using anti-OATP2 (synonymous 
with OATP1B1) and anti-OATP8 (synonymous with OATP1B3) 
antibodies (GTX15442, Genetex, Irvine, CA, USA). The slides 
Fig. 1. Characterization of HCC spontaneously developed in an 8.5-month-old H-Ras 12V transgenic mouse. (A) Gross examination of the dissected liv-
er revealed multiple tumor nodules. (B) Hematoxylin and eosin staining of the tumor periphery (magnification: left, ×40; right, ×200) revealed tumor 
cells with wide thickened trabeculae and mild cytologic atypia, similar to well-differentiated HCC. (C) Confocal images of immunofluorescence stain-
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were reviewed by a pathologist (J.C.) with 5 years of experience 
in experimental animal histopathology and human pathology. 
Only nodules diagnosed as HCC based on the morphologi-
cal features of the H&E-stained slides were analyzed. Tumor 
differentiation was assessed, and in the case of well-differenti-
ated tumors, the presence or absence of high-grade pathologi-
cal components such as tumor foci containing necrosis, thick-
ened trabeculae, and vascular invasion in more than 10% of the 
tumor surface was marked (Fig. 2). Immunohistochemistry of 
OATP-stained slides was performed to grade the intensities of 
OATP expression. The intensity of OATP expression was cate-
gorized into three grades (grade 0: negative; grade 1: weak pos-
itive; and grade 2: moderate to strong positive). The extent of 
OATP expression within the tumor was categorized into three 
grades (grade 1: OATP expression was detected in less than 
33% of the tumor; grade 2, between 33% and 67% of the tumor; 
grade 3, more than 67% of the tumor). 
Statistical analysis
Statistical analysis was performed using SPSS v.25 (IBM Corp., 
Armonk, NY, USA). Fisher’s exact test was performed to com-
pare the rate of tumor differentiation and intensity of OATP 
1B1/1B3 expression. Statistical significance was set at p<0.05.
RESULTS
Dissected livers from transgenic male mice with HCC at 8.5 
months of age revealed the development of multiple nodules 
(Fig. 1A). The larger nodules revealed prominent vessels on 
their surface. Hematoxylin and eosin staining revealed multi-
ple, well-vascularized nodules composed of well-differentiated 
tumor cells with wide thickened trabeculae and mild cytologic 
atypia (Fig. 1B). Confocal microscopy after immunofluorescence 
staining demonstrated increased expression of CD31, smooth 
muscle actin, and laminin in the tumor capillaries (Fig. 1C), but 
not in the sinusoidal capillaries. Based on these findings, we 
determined that the histological features of HCCs generated 
in this mouse model were similar to those of human HCC. 
Next, we performed gadoxetic acid-enhanced MRI, which 
revealed 44 liver nodules in nine mice. Many of these nodules 
were small and close to each other, which made the radiologi-
cal-pathological correlation difficult. Moreover, unlike the hu-
man liver, which has immovable lobes, the mouse liver con-
sisted of separate lobes that were connected to each other only 
at the hilum (Fig. 1A); therefore, the position of each lobe was 
not consistent. As a result, we were not able to confidently 
match some of the nodules on the specimen during dissection 
with the baseline MRI. Therefore, that radiology-pathology 
Fig. 2. Hematoxylin and eosin staining typical images of high-grade pathological components showing (A) widespread necrosis (arrows, magnifica-
tion: ×12.5), (B) thickened trabeculae (arrows, magnification: ×40), (C) vascular invasion (arrows, magnification: ×40), and (D) presence of high-grade 
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correlation was not performed.
In total, we harvested 59 HCCs from 13 male transgenic mice, 
and all of them were well-differentiated. Moderately and poorly 
differentiated HCCs were not detected. The tumors were fur-
ther graded into well-differentiated HCCs without high-grade 
pathological components (n=49) and well-differentiated HCCs 
with high-grade pathological components (n=10) (Fig. 2). Among 
the well-differentiated HCCs without high-grade pathological 
components (n=49), OATP expression was negative, weak pos-
itive, and moderate positive in 46.9% (n=23/49), 34.7% (n= 
Fig. 3. HCC in 10-month-old male H-Ras 12V transgenic mice. (A) Representative fat-suppressed T1 weighted image, obtained 15 min after gadoxetic 
acid injection, demonstrates nodules with (left) mild enhancement (white arrow) and (right) without enhancement (black arrow). (B) Hematoxylin and 
eosin-stained image and (C) immunohistochemistry of OATP 1B1/1B3 (left column). The nodule with mild enhancement on MRI was a well-differenti-
ated HCC with high-grade pathological components, such as necrosis (black arrows) and thick trabeculae (white arrows), and showed moderate 
positive OATP 1B1/1B3 expression (right column). The nodule without enhancement on MRI was a well-differentiated HCC without high-grade patho-
logical components, and the OATP 1B1/1B3 expression was negative. HCC, hepatocellular carcinoma; OATP, organic anion transporting polypeptides; 
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17/49), and 18.4% (n=9/49) of the tumors, respectively (Fig. 3). 
In the 10 well-differentiated HCCs with high-grade pathologi-
cal components, OATP expression was negative, weak positive, 
moderate positive in 10.0% (n=1/10), 20.0% (n=2/10), and 70.0% 
(n=7/10) of the tumors, respectively (Fig. 3). The well-differenti-
ated HCCs with high-grade pathological components had a 
higher rate of positive OATP 1B1/1B3 expression compared to 
that of HCCs without high-grade pathological components (p= 
0.004) (Table 1).
Among the 17 well-differentiated HCCs that showed weak 
positive OATP 1B1/1B3 expression, 10 tumors showed positive 
OATP expression in less than 33% of the tumor (grade 1), five 
tumors showed positive OATP expression in 33% to 67% (grade 
2), and two tumors showed positive OATP expression in more 
than 67% of the tumor (grade 3). In the nine HCCs that showed 
moderate positive OATP expression, one, one, and seven tu-
mors were grade 1, grade 2, and grade 3, respectively (Table 1).
In the well-differentiated HCCs with high-grade pathological 
components, the extent of OATP expression in the two OATP 
1B1/1B3 weak positive tumors was grade 1 (n=1) and grade 3 
(n=1) each. The extent of OATP 1B1/1B3 expression in the mod-
erate positive HCCs was grade 2 and grade 3 in two and five tu-
mors, respectively (Table 1). 
DISCUSSION
During multistep hepatocarcinogenesis, more aggressive tu-
mor clones with molecular alterations emerge within a less ag-
gressive tumor or premalignant nodule.25 As the increased 
numbers of aggressive tumor clones have a survival advantage, 
they will eventually replace the less aggressive precursor lesion, 
which can be detected during histological evaluation.5,26 Mu-
tations then successively accumulate, producing molecular 
derangements that may correlate with tumor differentiation. 
In this process, if molecular alterations influence the OATP 
1B1/1B3 signaling pathway, the enhancement of gadoxetic 
acid on HCC hepatobiliary phase MRI images may theoreti-
cally reveal a definable pattern linked to tumor differentiation. 
For instance, OATP1B3 has been reported to interact with he-
patocyte nuclear factor 4α, forkhead box M1, and β-catenin 
signaling pathways.6,27-31 Kitao, et al.6 reported that hyperin-
tense (OATP1B3-high) HCC and hypointense (OATP1B3-low) 
HCC can represent genetically different subtypes. 
It is well-known that the hepatobiliary phase enhancement 
of gadoxetic acid-enhanced MRI correlates with the degree of 
OATP1B3 expression in HCC, and therefore is considered as 
an indirect molecular imaging marker.5,6,13 Previous studies 
have reported that hepatobiliary phase hyperintense HCC dem-
onstrate more frequent pseudoglandular proliferation pattern 
and bile plug formation, and lower rate of portal vein invasion 
rate.6,12 Hepatobiliary phase hyperintense HCCs were also as-
sociated with lower levels of tumor markers such as alpha fe-
toprotein and protein induced by vitamin K absence or antag-
onist.6,12,32,33 Moreover, hepatobiliary phase hyperintense HCCs 
showed lower recurrence rate and longer survival after surgi-
cal resection.6,12,32-34
Most HCCs demonstrate decreased signal intensity in the 
hepatobiliary phase of gadoxetic acid-enhanced MRI, but par-
adoxical enhancement occurs in a subgroup of HCC.7,11-13 How-
ever, the relationship between tumor differentiation and hepa-
tobiliary phase enhancement has been controversial. Some 
researchers have reported that such paradoxical enhancement 
is limited to well-differentiated HCCs,18,19,35 whereas others 
have indicated that it also occurs in moderately differentiated 
HCCs.17 One study claimed that no correlation existed between 
paradoxical enhancement and HCC differentiation.20 Mean-
while, other studies have indicated that paradoxical enhance-
ment is predominately associated with moderately differenti-
ated HCCs.8,13,36 
The hepatobiliary enhancement that was observed only in 
well-differentiated HCCs18,19,35 seem plausible as the hepato-
biliary enhancement may be localized in the initial benign 
nodules of well-differentiated HCC where physiological levels 
of OATP 1B1/1B3 is maintained. It can be hypothesized that 
OATP 1B1/1B3 activity diminishes as hepatocarcinogenesis 
progresses to worsen tumor differentiation. In contrast, studies 
describing paradoxical enhancement as an event predominantly 
appearing in moderately differentiated HCCs8,13,36 are somewhat 
more challenging to explain, as this suggests that OATP 1B1/1B3 
expression has to fluctuate by being temporally suppressed 
(well-differentiated stage), reactivated (moderately differentiat-
ed stage), and then again suppressed (poorly differentiated 
stage). Alternatively, some researchers have simply explained 
this as enhanced HCCs developing from hypointense border-
line lesions due to genetic or epigenetic alterations.6,13 




without high grade pathological component
Well-differentiated HCC 
with high grade pathological components
p value
OATP intensity
Negative Weak positive Moderate  positive Negative Weak positive Moderate  positive
23 17 9 1 2 7 0.004
OATP extent*
- G1/G2/G3 G1/G2/G3 - G1/G2/G3 G1/G2/G3 -
- 10/5/2 1/1/7 - 1/0/1 0/2/5 -
OATP, organic anion transporting polypeptides; HCC, hepatocellular carcinoma.
*G1: OATP expression was detected in less than 33% of the tumor, G2: between 33% and 67% of the tumor, G3: more than 67% of the tumor.
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We speculated that such contradicting observations could 
be, at least partly, influenced by observational errors caused 
by substantial inter-individual variation among study popula-
tions. Different predisposing factors, such as oncogenic stim-
uli, genetic background, and environmental factors, may also 
contribute to the observational differences. The combined ef-
fect of these variations may have had an impact on the multi-
step hepatocarcinogenesis and OATP 1B1/1B3 signaling path-
ways, complicating the HCC enhancement profile of gadoxetic 
acid-enhanced MRI and its relationship with tumor differen-
tiation. 
Based on this perspective, we examined the relationship be-
tween tumor differentiation and OATP 1B1/1B3 expression pro-
files in a standardized system in which HCC develops under 
uniform stimulus with minimal inter-individual variations. We 
used the H-Ras 12V transgenic mice as we speculated that this 
model would develop HCC driven by a uniform oncogenic stim-
ulus (H-Ras oncogene) at a relatively consistent amplitude. 
Moreover, as these mice are syngeneic, they have little difference 
in genetic background. The mice feed on the same diet and live in 
an identical environment, unlike human patients; therefore, the 
differences in environmental factors and lifestyle are negligible. 
Therefore, we hypothesized that this mouse model should have 
minimal inter-individual differences and could help clarify the 
relationship between tumor differentiation and OATP 1B1/1B3 
expression.
Before immunohistochemistry, we first examined the histo-
logical features of HCCs generated in H-Ras 12V transgenic mice 
to validate the tumor model. Hematoxylin and eosin staining re-
vealed morphological similarities with those of human HCCs, 
such as thickened trabeculae with cytologic atypia and capil-
larization. Occasional necrotic foci and thick cords of tumor 
cells were also observed. Immunofluorescence staining revealed 
prominent expression of CD31, laminin, and smooth muscle 
actin in the tumor capillaries, indicating that sinusoidal capil-
larization and arterialization had occurred.37 The HCCs gener-
ated in this mouse model have been described to induce the 
formation of tumor-feeding vessels from the hepatic artery that 
gradually replace the physiologic portal venous perfusion, sim-
ilar to human HCC patients.23 One study on gadoxetic acid-en-
hanced MRI using this mouse model reported that the HCCs 
mostly revealed low signal intensity on T1 weighted images af-
ter enhancement in the delayed phase, but 16.1% of the lesions 
presented with nodule-in-nodule appearance.21 Based on these 
results and studies, we concluded that the HCCs generated in 
the H-Ras 12V mice closely resemble the histologic, vascular, 
and MRI features of human HCC. Therefore, these mice can 
serve as a robust experimental platform for recapitulating hu-
man HCC.
Next, we harvested 59 HCCs, which were all confirmed as well-
differentiated tumors. The majority of the tumors were well-dif-
ferentiated HCCs without high-grade pathological components 
(n=49), but some HCCs (n=10) contained high-grade patholog-
ical components. As both OATP1B3 and OATP1B1 transports 
gadoxetic acid into hepatocytes and therefore enhances the 
hepatobiliary phase,3,38 we performed immunohistochemistry 
with an antibody cross-reactive for both carrier proteins. Ap-
proximately half of the well-differentiated HCCs without high-
grade pathological components were OATP 1B1/1B3 negative 
(46.9%; n=23/49), whereas only 10.0% (n=1/10) of well-differ-
entiated HCCs with high-grade pathological components were 
OATP 1B1/1B3 negative. In contrast, the proportion of OATP 
1B1/ 1B3 moderate-intensity HCCs was 18.4% (n=9/49) in well-
differentiated HCCs without high-grade pathological compo-
nents, but 70.0% (n=7/10) in well-differentiated HCCs with 
high-grade pathological components (Table 1 and Fig. 4). We be-
lieve that the higher ratio of OATP 1B1/1B3-positive HCC ob-
served in well-differentiated HCCs with high-grade pathologi-
cal components indicates that OATP 1B1/1B3-positive tumor 
cells must have increased as tumor differentiation worsened. 
Therefore, our observation supports the results of a previous 
clinical study that reported paradoxical enhancement of the 
hepatobiliary phase of gadoxetic acid-enhanced MRI to be a 
phenomenon that is predominantly associated with moder-
ately differentiated HCCs.8 
Our study had a few limitations. First, we used a genetically 
modified mouse to establish HCC. However, the HCC patho-
genesis in this mouse model was different compared to that in 
humans, in which various underlying diseases, such as chronic 
viral hepatitis, induce HCC. Nevertheless, we specifically se-
lected a standardized tumor model driven by a uniform onco-
genic stimulus to minimize inter-individual variation. Second, 
as mentioned above, we were not able to perform a radiology-
Fig. 4. Schematic graph depicting the relation between the presence or 
absence of high-grade pathological tumor component and OATP 1B3/1B1 
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pathology correlation, since we could not confidently differenti-
ate the tumors crowded within the small liver and match them 
on the MRI. However, considering the importance of OATP 
1B1/1B3 in liver imaging, we believe that examining the expres-
sion pattern of these molecules in a standardized mouse HCC 
model is still meaningful. Third, our model only produced well-
differentiated HCCs, and therefore, poorly differentiated HCCs 
were not examined. We believe that the short life span of the 
mice did not allow sufficient incubation time for the tumors 
to undergo multistep hepatocarcinogenesis to generate poorly 
differentiated tumors. However, most of the controversy regard-
ing the OATP expression pattern in HCC was focused on the 
well-differentiated and moderately differentiated stages, and 
not the poorly differentiated stage of tumors. Therefore, we 
considered the inability of our model to produce poorly differ-
entiated HCC as a minor limitation. In our study, we divided 
the well-differentiated HCCs according to the presence or ab-
sence of high-grade pathological components for comparison 
of tumor differentiation.  
In conclusion, well-differentiated HCCs generated in H-Ras 
12V transgenic mice revealed an increased OATP 1B1/1B3 ex-
pression ratio in tumors with high-grade pathological compo-
nents. Our results support clinical studies that reported para-
doxical hepatobiliary phase enhancement of gadoxetic acid-
enhanced MRI in moderately differentiated HCC.
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